AIM contributed to an OECD Online Consultation on sustainable access to innovative therapies. AIM is of the opinion that a broad political and societal discussion is needed about what a fair price is for pharmaceuticals. Discussions about fairness of prices require transparency of prices, transparency of costs made in the field of R&D and require better insight in the efficacy and relative effectiveness of pharmaceuticals. The full contribution to the OECD consultation can be found here
26 April – AIM publishes its position on social economy. The paper lays out AIM members’ position on the key concepts of ‘social economy’ and explains why mutuals fit in this category and the importance of a clear definition of the concept. The document also outlines the specific policy needs of social economy enterprises with a focus on mutuals.
Continue reading “AIM publishes position on Social Economy”
The European Alliance for Mental Health in All Policies (EUMHAlliance), of which AIM is a member, published a Press Release on the occasion of World Health Day. The PR calls for an investment in mental-health promotion, prevention and recovery from mental illness as well as stigma reduction at work.
Read our opinion: Our answer to the consultation on Excise Duties on Tobacco.